Saturday, 15 May, 2021
Home Business Dr Reddy's Gains Nearly 1% On Launching Albendazole Tablets In U.S.

Dr Reddy's Gains Nearly 1% On Launching Albendazole Tablets In U.S.

At 10:40 am, Dr. Reddy’s Laboratories shares have been buying and selling greater by 0.82 per cent on BSE

Dr Reddy’s Laboratories shares gained practically one per cent on the BSE after the corporate introduced the launch of albendazole tablets within the US market. At 10:40 am, the shares of Dr. Reddy’s Laboratories have been buying and selling at Rs 5,143, greater by 0.82 per cent on the BSE.

Albendazole tablets are a therapeutic equal generic model of Albenza tablets, 200 mg, accredited by the U.S. Meals and Drug Administration.

The Albenza model and generic had U.S. gross sales of about $27 million MAT for the twelve months ended November 2020.

The albendazole tablets can be found in 200 mg tablets in bottle depend sizes of two.

The Sensex was buying and selling at 49,427.75, decrease by 344.49 factors or 0.71 per cent and the NSE Nifty was at 14,807.90, down 84.10 ponts or 0.46 per cent on the time.

Most Popular

Ayushmann Khurrana on his next with Abhishek Kapoor: It is a beautiful, progressive love story

By: Leisure Desk | New Delhi | Revealed: July 29, 2020 8:43:23 am Ayushmann Khurrana and Abhishek Kapoor movie will launch subsequent 12...

Poll Body Seeks Detailed Report On Kamal Nath's "Item" Remark

Kamal Nath referred to lady minister as an "merchandise", sparking an argument. (File)New Delhi: The Election Fee of India (ECI) has sought an in...

Who is Dhanashree Verma?

By: Leisure Desk | New Delhi | Revealed: August 8, 2020 6:42:23 pm Dhanashree Verma is a YouTuber and dancer by career. (Picture:...
English English हिन्दी हिन्दी ਪੰਜਾਬੀ ਪੰਜਾਬੀ